While IL15 deletion in tumour cells correlated with decreased IL-15 expression and poor clinical prognosis in colorectal cancers37, high level of IL-15 was associated with increased inflammation and poor clinical outcome in head and neck cancer38. The gene discussed is IL15; the disease is neoplasm.